View in EDS HTML Full Text PDF Full Text

Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Saved in:

Bibliographic Details
Title:	Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.
Authors:	Braunstein, Zachary¹ (AUTHOR) Jonathan.brammer@osumc.edu, Waller, Allyson² (AUTHOR), Dotson, Emily² (AUTHOR), McLaughlin, Eric³ (AUTHOR), Hanel, Walter⁴ (AUTHOR), Reneau, John⁴ (AUTHOR), Addison, Daniel⁵ (AUTHOR), Porcu, Pierluigi⁶ (AUTHOR), Brammer, Jonathan Edward⁴ (AUTHOR)
Source:	Leukemia & Lymphoma. Mar2024, Vol. 65 Issue 3, p301-311. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	10428194
DOI:	10.1080/10428194.2023.2287965